HIV Protease Inhibitor Synthesis via Segmented Reduction and Deprotection

The patent divides the simultaneous reduction and deprotection reaction into two separate steps: first performing the reduction of the nitro moiety, then subsequently performing the Cbz deprotection. This segmentation allows each reaction to be controlled independently, avoiding the highly exothermic conditions that occur when both reactions are performed simultaneously, thus resolving the contradiction between reduced reaction time and temperature control.

The patent introduces an acid treatment step before the catalytic reduction. This preliminary acid treatment removes the sulfur contaminant from the p-nitrobenzenesulfonyl-chloride reagent, preventing catalyst poisoning during the subsequent reduction step. This resolves the contradiction by maintaining process simplicity while ensuring catalyst reliability through a preliminary preparatory step.

The patent segments the reaction process into separate, controlled steps rather than performing a single high-temperature exothermic reaction. Each step is conducted under controlled temperature conditions that maintain adequate mixing while achieving the desired reaction rate, thus resolving the contradiction between productivity and manufacturing precision.

The patent extracts and removes the unnecessary intermediate purification steps from the process. By optimizing the reaction conditions and using selective reagents, the patent achieves high product purity directly without requiring additional purification operations, thus resolving the contradiction between product purity and process complexity.